Our data show that the IL‐11/IL‐11RA axis from tumour cells conducts the TME towards an immunosuppressive landscape and indicate that IL‐11 modulates the TME mainly by impairing T cell infiltration and by incrementing macrophage levels. The gene discussed is IL11; the disease is neoplasm.